BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $1.35 and last traded at $1.32, with a volume of 37345 shares trading hands. The stock had previously closed at $1.34.
BioRestorative Therapies Stock Performance
The stock’s 50 day simple moving average is $1.44 and its 200 day simple moving average is $1.70. The firm has a market cap of $2.16 billion, a P/E ratio of -0.03 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- Consumer Staples Stocks, Explained
- The Charles Schwab Company Can Hit New Highs
- ETF Screener: Uses and Step-by-Step Guide
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20221121151525&h=45&w=95&zc=2){kind=logo}
